Drug intelligence / Profile preview

SIRT6-mRNA.018

Development stage
Preclinical
Lead developer
SirtLab
Modality
mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intravenous, Parenteral
01

Overview

SIRT6-mRNA.018 is an mRNA-based therapeutic developed by SirtLab, designed to transiently increase the expression and activity of the SIRT6 protein. SIRT6 is a member of the sirtuin family of NAD+-dependent deacetylases, known for its roles in DNA repair, metabolic regulation, and longevity. The drug utilizes a lipid nanoparticle (LNP) delivery system to transport SIRT6-encoding mRNA into cells. It is currently in IND-enabling studies, with primary development focuses on post-surgical recovery (resilience and function) and longevity in adults aged 50 and above. Potential broad applications include metabolic and cardiovascular conditions such as non-alcoholic fatty liver disease (NAFLD), type 2 diabetes, and metabolic syndrome.

Other names
mRNA-LNP Longevity-Frailty
02

Targets

SIRT6 (Sirtuin 6)

Beyond the preview

Go deeper on SIRT6-mRNA.018.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SIRT6-mRNA.018.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call